Emerging principles of conformation-based prion inheritance.

The prion hypothesis proposes that proteins can act as infectious agents. Originally formulated to explain transmissible spongiform encephalopathies (TSEs), the prion hypothesis has been extended with the finding that several non-Mendelian traits in fungi are due to heritable changes in protein conformation, which may in some cases be beneficial. Although much remains to be learned about the specific role of cellular cofactors, mechanistic parallels between the mammalian and yeast prion phenomena point to universal features of conformation-based infection and inheritance involving propagation of ordered beta-sheet-rich protein aggregates commonly referred to as amyloid. Here we focus on two such features and discuss recent efforts to explain them in terms of the physical properties of amyloid-like aggregates. The first is prion strains, wherein chemically identical infectious particles cause distinct phenotypes. The second is barriers that often prohibit prion transmission between different species. There is increasing evidence suggesting that both of these can be manifestations of the same phenomenon: the ability of a protein to misfold into multiple self-propagating conformations. Even single mutations can change the spectrum of favored misfolded conformations. In turn, changes in amyloid conformation can shift the specificity of propagation and alter strain phenotypes. This model helps explain many common and otherwise puzzling features of prion inheritance as well as aspects of noninfectious diseases involving toxic misfolded proteins.

[1]  C. King,et al.  Supporting the structural basis of prion strains: induction and identification of [PSI] variants. , 2001, Journal of molecular biology.

[2]  B Frangione,et al.  Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. , 2000, The Journal of biological chemistry.

[3]  S. Prusiner,et al.  Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Lehrach,et al.  Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin , 2003, Journal of Biological Chemistry.

[5]  S. Prusiner,et al.  Inherited prion disease caused by the V210I mutation , 2001, Neurology.

[6]  B. Chesebro,et al.  A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells , 1995, Journal of virology.

[7]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[8]  Daniel I. C. Wang,et al.  Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition , 1996, Nature Biotechnology.

[9]  G. Friedlander,et al.  Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. , 2002, Biochemistry.

[10]  H. True,et al.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.

[11]  P E Fraser,et al.  A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Marsh,et al.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent , 1992, Journal of virology.

[13]  Roger Cooke,et al.  Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.

[14]  V. Uversky,et al.  Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.

[15]  J. Weissman,et al.  Origins and kinetic consequences of diversity in Sup35 yeast prion fibers , 2002, Nature Structural Biology.

[16]  M. Tuite,et al.  The Candida albicans Sup35p protein (CaSup35p): function, prion-like behaviour and an associated polyglutamine length polymorphism. , 2002, Microbiology.

[17]  G. C. Millson,et al.  Scrapie produced experimentally in goats with special reference to the clinical syndrome. , 1961, Journal of comparative pathology.

[18]  S. Supattapone,et al.  In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. , 2003, Biochemistry.

[19]  P. Zhou,et al.  The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast , 1999, Current Genetics.

[20]  L. Serpell,et al.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.

[21]  J. Weissman,et al.  The utility of prions. , 2002, Developmental cell.

[22]  C. Cullin,et al.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead‐end products , 2003, The EMBO journal.

[23]  F. Cohen,et al.  Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.

[24]  C. Dobson,et al.  Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. , 2000, Journal of structural biology.

[25]  S. Liebman,et al.  Isolation of omnipotent suppressors in an [eta+] yeast strain. , 1990, Genetics.

[26]  S. Prusiner,et al.  Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  I. Mcconnell,et al.  A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy , 1999, The EMBO journal.

[28]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[29]  Kiowa S. Bower,et al.  Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. , 2002, Neurotoxicology.

[30]  E. Mandelkow,et al.  A nucleated assembly mechanism of Alzheimer paired helical filaments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Vorberg,et al.  Molecular Basis of Scrapie Strain Glycoform Variation* , 2002, The Journal of Biological Chemistry.

[32]  Rahul S. Rajan,et al.  Specificity in intracellular protein aggregation and inclusion body formation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Y. Chernoff,et al.  Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae , 1993, Current Genetics.

[34]  F. Cohen,et al.  Prion Protein of 106 Residues Creates an Artificial Transmission Barrier for Prion Replication in Transgenic Mice , 1999, Cell.

[35]  Susan Lindquist,et al.  Prions as protein-based genetic elements. , 2002, Annual review of microbiology.

[36]  Yoshikazu Nakamura,et al.  Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. , 2001, Molecular cell.

[37]  C. Nierras,et al.  The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. , 1994, Genetics.

[38]  J. Weissman,et al.  Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. , 2000, Science.

[39]  B. Permanne,et al.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.

[40]  M. Tranulis Influence of the prion protein gene, Prnp, on scrapie susceptibility in sheep , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[41]  S. Lindquist,et al.  [PSI+], SUP35, and chaperones. , 2001, Advances in protein chemistry.

[42]  H. Fraser,et al.  Modification of the Pathogenesis of Scrapie in Mice by Treatment of the Agent , 1969, Nature.

[43]  S. Duvezin-Caubet,et al.  Amyloid aggregates of the HET-s prion protein are infectious , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Fraser,et al.  Morphology and antibody recognition of synthetic β‐amyloid peptides , 1991 .

[45]  F. Cohen,et al.  Strain‐specified relative conformational stability of the scrapie prion protein , 2001, Protein science : a publication of the Protein Society.

[46]  U Aebi,et al.  Polymorphic fibrillar assembly of human amylin. , 1997, Journal of structural biology.

[47]  D A Smith,et al.  Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.

[48]  R. Wickner,et al.  [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. , 1994, Science.

[49]  P. Fraser,et al.  Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. , 1994, Journal of molecular biology.

[50]  J. Collinge,et al.  Protease-resistant prion protein produced in vitro lacks detectable infectivity. , 1999, The Journal of general virology.

[51]  P. Lansbury,et al.  Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Richardson,et al.  Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. J. Raymond,et al.  Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[55]  C. Cullin,et al.  The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele , 2000, The EMBO journal.

[56]  K Wüthrich,et al.  NMR structure of the bovine prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Wickner,et al.  Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Prusiner,et al.  Further purification and characterization of scrapie prions. , 1982, Biochemistry.

[59]  F E Cohen,et al.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Wickner,et al.  Prion-Inducing Domain of Yeast Ure2p and Protease Resistance of Ure2p in Prion-Containing Cells , 1995, Science.

[61]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[62]  F. Cohen,et al.  Separation of scrapie prion infectivity from PrP amyloid polymers. , 1996, Journal of molecular biology.

[63]  P. Lansbury,et al.  Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. , 1990, Biochemistry.

[64]  S. Paushkin,et al.  In vitro propagation of the prion-like state of yeast Sup35 protein. , 1997, Science.

[65]  Arthur L Horwich,et al.  Deadly Conformations—Protein Misfolding in Prion Disease , 1997, Cell.

[66]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[67]  M. Citron,et al.  alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.

[68]  R. Wickner,et al.  Prion domain initiation of amyloid formation in vitro from native Ure2p. , 1999, Science.

[69]  Stephen J. DeArmond,et al.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.

[70]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[71]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[72]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[73]  H. Fraser,et al.  Transmission of bovine spongiform encephalopathy and scrapie to mice. , 1992, The Journal of general virology.

[74]  M. Palmer,et al.  Unaltered susceptibility to BSE in transgenic mice expressing human prion protein , 1995, Nature.

[75]  C. Masters,et al.  Evidence for and against the transmissibility of Alzheimer disease , 1980, Neurology.

[76]  Vladimir N Uversky,et al.  Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. , 2002, Neurotoxicology.

[77]  S. Rapoport,et al.  Blood buffy coat from Alzheimer's disease patients and their relatives does not transmit spongiform encephalopathy to hamsters , 1994, Neurology.

[78]  S W Liebman,et al.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. , 1995, Science.

[79]  L. Hood,et al.  Purification and structural studies of a major scrapie prion protein , 1984, Cell.

[80]  S. Lindquist,et al.  Rnq1: an epigenetic modifier of protein function in yeast. , 2000, Molecular cell.

[81]  J. Aiken,et al.  Adaptation and Selection of Prion Protein Strain Conformations following Interspecies Transmission of Transmissible Mink Encephalopathy , 2000, Journal of Virology.

[82]  S. Prusiner,et al.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Lindquist,et al.  Strains of [PSI+] are distinguished by their efficiencies of prion‐mediated conformational conversion , 2001, The EMBO journal.

[84]  R. Wickner,et al.  Interactions among prions and prion “strains” in yeast , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  L. Serpell,et al.  The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.

[86]  R. Wetzel,et al.  Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. , 1996, Journal of molecular biology.

[87]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[88]  M. Maddelein,et al.  In vivo aggregation of the HET‐s prion protein of the fungus Podospora anserina , 2001, Molecular microbiology.

[89]  F. Cohen,et al.  Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Prusiner,et al.  A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain , 2002, Neuron.

[91]  Y. Chernoff,et al.  Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. , 1996, Genetics.

[92]  S. Priola,et al.  Glycosylation influences cross‐species formation of protease‐resistant prion protein , 2001, The EMBO journal.

[93]  G. J. Raymond,et al.  Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease , 2000, The EMBO journal.

[94]  M. Tuite,et al.  The [URE3] phenotype: evidence for a soluble prion in yeast , 2002, EMBO reports.

[95]  C. Weissmann,et al.  A 'unified theory' of prion propagation , 1991, Nature.

[96]  V. Smirnov,et al.  [PSI+] prion generation in yeast: characterization of the ‘strain’ difference , 2001, Yeast.

[97]  J T Finch,et al.  Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  I. Mcconnell,et al.  PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[99]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[100]  I. Herskowitz,et al.  Induction of Distinct [URE3] Yeast Prion Strains , 2001, Molecular and Cellular Biology.

[101]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[102]  F. Cohen,et al.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein , 1995, Cell.

[103]  J. Collinge,et al.  BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein , 2002, The EMBO journal.

[104]  I D Campbell,et al.  Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[105]  D. Melton,et al.  Changing a single amino acid in the N‐terminus of murine PrP alters TSE incubation time across three species barriers , 2001, The EMBO journal.

[106]  I. Lascu,et al.  The HET-s Prion Protein of the Filamentous Fungus Podospora anserina Aggregates in Vitro into Amyloid-like Fibrils* , 2002, The Journal of Biological Chemistry.

[107]  S. Liebman,et al.  The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion‐like elements [PSI+] and [PIN+] , 2001, Molecular microbiology.

[108]  Jonathan S Weissman,et al.  Multiple Gln/Asn-Rich Prion Domains Confer Susceptibility to Induction of the Yeast [PSI+] Prion , 2001, Cell.

[109]  D. Masison,et al.  Antagonistic Interactions between Yeast [PSI+] and [URE3] Prions and Curing of [URE3] by Hsp70 Protein Chaperone Ssa1p but Not by Ssa2p , 2002, Molecular and Cellular Biology.

[110]  P. Lansbury,et al.  Non-genetic propagation of strain-specific properties of scrapie prion protein , 1995, Nature.

[111]  H. Fraser,et al.  The sequential development of the brain lesion of scrapie in three strains of mice. , 1968, Journal of comparative pathology.

[112]  E. Coissac,et al.  Conservation of the prion properties of Ure2p through evolution. , 2003, Molecular biology of the cell.

[113]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[114]  R. Diaz-Avalos,et al.  Protein-only transmission of three yeast prion strains , 2004, Nature.

[115]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[116]  H. Vinters,et al.  Stereochemical specificity of Alzheimer's disease β-peptide assembly , 1999 .

[117]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[118]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[119]  V. Jansen,et al.  The kinetics of proteinase K digestion of linear prion polymers , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[120]  R. Wetzel Ideas of order for amyloid fibril structure. , 2002, Structure.

[121]  M. Enari,et al.  Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[122]  V. Uversky,et al.  Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein* , 2003, Journal of Biological Chemistry.

[123]  J R Glover,et al.  Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.

[124]  J. Weissman,et al.  Conformational diversity in a yeast prion dictates its seeding specificity , 2001, Nature.

[125]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[126]  Peter T. Lansbury,et al.  Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.

[127]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[128]  H. Nakanishi,et al.  pH-dependent aggregate forms and conformation of Alzheimer amyloid beta-peptide (12-24). , 2002, Journal of biochemistry.

[129]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[130]  M. Tuite,et al.  Mechanism of inhibition of Ψ+ prion determinant propagation by a mutation of the N‐terminus of the yeast Sup35 protein , 1998, The EMBO journal.

[131]  F E Cohen,et al.  A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.

[132]  U. Baxa,et al.  Architecture of Ure2p Prion Filaments , 2003, Journal of Biological Chemistry.

[133]  B. Roberts,et al.  Yeast prions act as genes composed of self-propagating protein amyloids. , 2001, Advances in protein chemistry.

[134]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[135]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[136]  Christopher M Dobson,et al.  The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.

[137]  Y. Chernoff,et al.  Evolutionary conservation of prion‐forming abilities of the yeast Sup35 protein , 2000, Molecular microbiology.

[138]  F. Cohen,et al.  Prion Protein Biology , 1998, Cell.

[139]  C. Gibbs,et al.  SLOW, LATENT AND TEMPERATE VIRUS INFECTIONS , 1967 .

[140]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[141]  F E Cohen,et al.  Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.

[142]  M. Tuite,et al.  Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion‐mediated mechanism , 1999, The EMBO journal.

[143]  S. Lindquist,et al.  Creating a protein-based element of inheritance. , 2000, Science.

[144]  Alasdair C Steven,et al.  Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[145]  V. Coustou,et al.  The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[146]  J. Collinge,et al.  Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.

[147]  J. Doucet,et al.  The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. , 2003, Journal of structural biology.

[148]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[149]  V. Smirnov,et al.  The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. , 1994, Genetics.

[150]  C. Dobson,et al.  Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. , 2001, Journal of molecular biology.

[151]  Sean R. Collins,et al.  Generation of prion transmission barriers by mutational control of amyloid conformations , 2003, Nature.

[152]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[153]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[154]  T. Fujita,et al.  Analysis of yeast prion aggregates with amyloid-staining compound in vivo. , 2003, Cell structure and function.

[155]  F. Heppner,et al.  Immune system and peripheral nerves in propagation of prions to CNS. , 2003, British medical bulletin.

[156]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[157]  S. Liebman,et al.  Prions Affect the Appearance of Other Prions The Story of [PIN+] , 2001, Cell.

[158]  J. Collinge Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[159]  S. Lindquist,et al.  The role of conformational flexibility in prion propagation and maintenance for Sup35p , 2001, Nature Structural Biology.

[160]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[161]  B. Roberts,et al.  Heritable activity: a prion that propagates by covalent autoactivation. , 2003, Genes & development.

[162]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[163]  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[164]  G. J. Raymond,et al.  Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein* , 1998, The Journal of Biological Chemistry.

[165]  R. Wickner,et al.  Prion Filament Networks in [Ure3] Cells of Saccharomyces cerevisiae , 2001, The Journal of cell biology.

[166]  J. Kemp,et al.  Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis , 2002, Nature.

[167]  M. Boguta,et al.  Chaperones that cure yeast artificial [PSI +] and their prion-specific effects , 2000, Current Biology.

[168]  K. Wüthrich,et al.  Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[169]  Y. Chernoff,et al.  Yeast prion protein derivative defective in aggregate shearing and production of new ‘seeds’ , 2001, The EMBO journal.

[170]  R. Somerville,et al.  Characterization of Thermodynamic Diversity between Transmissible Spongiform Encephalopathy Agent Strains and Its Theoretical Implications* , 2002, The Journal of Biological Chemistry.

[171]  A. Miranker,et al.  Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. , 2002, Biochemistry.

[172]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[173]  S. Paushkin,et al.  Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor. , 1996, The EMBO journal.

[174]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[175]  P. Lantos,et al.  Species-barrier-independent prion replication in apparently resistant species. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[176]  J. Weissman,et al.  Molecular Basis of a Yeast Prion Species Barrier , 2000, Cell.

[177]  M. Ter‐Avanesyan,et al.  Prion properties of the Sup35 protein of yeast Pichia methanolica , 2000, The EMBO journal.

[178]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[179]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[180]  S. Lindquist,et al.  The yeast non‐Mendelian factor [ETA+] is a variant of [PSI+], a prion‐like form of release factor eRF3 , 1999, The EMBO journal.

[181]  E. Kandel,et al.  A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.

[182]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[183]  S. Lindquist,et al.  Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.

[184]  R. Kimberlin,et al.  Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. , 1987, The Journal of general virology.

[185]  A. Aguzzi,et al.  High Prion and PrPSc Levels but Delayed Onset of Disease in Scrapie-Inoculated Mice Heterozygous for a Disrupted PrP Gene , 1994, Molecular medicine.

[186]  J. Weissman,et al.  A Critical Role for Amino-Terminal Glutamine/Asparagine Repeats in the Formation and Propagation of a Yeast Prion , 1998, Cell.

[187]  B. Chesebro,et al.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.

[188]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[189]  S. Lindquist,et al.  Hsp104, Hsp70, and Hsp40 A Novel Chaperone System that Rescues Previously Aggregated Proteins , 1998, Cell.

[190]  D. Thirumalai,et al.  Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.

[191]  S. Prusiner,et al.  Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[192]  E. M. Jones,et al.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: Structural clues for prion propagation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[193]  S. Liebman,et al.  Dependence and independence of [PSI+] and [PIN+]: a two‐prion system in yeast? , 2000, The EMBO journal.

[194]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[195]  S. Supattapone,et al.  RNA molecules stimulate prion protein conversion , 2003, Nature.

[196]  P. Lansbury,et al.  Cell-free formation of protease-resistant prion protein , 1994, Nature.

[197]  S. Prusiner,et al.  Identification of a protein that purifies with the scrapie prion. , 1982, Science.

[198]  J. Rossier,et al.  Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.

[199]  B. Chesebro,et al.  A View from the Top--Prion Diseases from 10,000 Feet , 2003, Science.

[200]  M. Baldwin Mass spectrometric analysis of prion proteins. , 2001, Advances in protein chemistry.

[201]  H. Fraser,et al.  The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. , 1991, The Journal of general virology.